Generics 173

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lumefantrine manufacturers

173 products found

Filters

173 products found

artemether + lumefantrine

Tablets 20 mg + 120 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Angola , Mozambique , Vietnam , Yemen
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #1377
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, North America, Africa, and Asia for 200+ years. Key production lines are Rx, OTC, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. Main dosage forms include solids, liquids, semi-solids, and sterile forms.

Manufacturer usually replies in 11 days

artemether + lumefantrine

Oral suspension 20 mg + 120 mg/5 ml - 60 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
United Kingdom
Manufacturer #33720

Established in 1992, this UK-based pharmaceutical manufacturer specializes in the development, manufacturing, marketing, and distribution of a wide range of medicines and supplements. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company's diverse product portfolio includes categories such as Cold & Cough, Pain Relief (Oral and Non-oral), Antibiotics, Antihypertensives, Antifungals, Anti-malarials, Supplements, Antacids, Anthelmintics, and other therapeutic areas. Operating advanced production lines adhering to stringent GMP guidelines, the manufacturer distributes its products across multiple countries worldwide.

Manufacturer usually replies in nan days

artemether + lumefantrine

Tablets 80 mg + 480 mg, 20 mg + 120 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
United Kingdom
Manufacturer #33720

Established in 1992, this UK-based pharmaceutical manufacturer specializes in the development, manufacturing, marketing, and distribution of a wide range of medicines and supplements. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company's diverse product portfolio includes categories such as Cold & Cough, Pain Relief (Oral and Non-oral), Antibiotics, Antihypertensives, Antifungals, Anti-malarials, Supplements, Antacids, Anthelmintics, and other therapeutic areas. Operating advanced production lines adhering to stringent GMP guidelines, the manufacturer distributes its products across multiple countries worldwide.

Manufacturer usually replies in nan days

Want to see all 173 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions. The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate. The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible